(Q40393680)

20 September 2017

1 reference

title

Prostate cancer kills: strategy to reduce deaths (English)

1 reference

20 September 2017

Prostate cancer kills: Strategy to reduce deaths (English)

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80039-1

17 May 2024

1 reference

P. C. Walsh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524232

17 May 2024

language of work or name

English

0 references

publication date

1 October 1994

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:S0090429594800391?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80039-1

https://api.elsevier.com/content/article/PII:S0090429594800391?httpAccept=text/plain

17 May 2024

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80039-1

17 May 2024

1 reference

20 September 2017

volume

44

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

463-466

1 reference

Questioning the value of screening for prostate cancer in asymptomatic men

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980039-1

7 January 2021

Risk factors for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980039-1

7 January 2021

Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980039-1

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980039-1

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980039-1

7 January 2021

High 10-year survival rate in patients with early, untreated prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980039-1

7 January 2021

Deferred treatment in clinically localised prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980039-1

7 January 2021

Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980039-1

7 January 2021

Update of EORTC clinical trials in prostate cancer. The EORTC Genito-Urinary Group

series ordinal

14

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80039-1

17 May 2024

Identifiers

1 reference

20 September 2017

1 reference